Gene · 5144
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Harmine inhibits non-small cell lung cancer growth by targeting phosphodiesterase4D and inducing ferroptosis. | Phytomedicine | 2026 | 41344272 | PubTator, text mining | PubMed |
| Recent development in PDE4D-targeted inhibitors for Alzheimer's disease therapy. | Eur J Med Chem | 2026 | 41265254 | PubTator, text mining | PubMed |
| Phosphodiesterase 4B (PDE4B) inhibitors and their applications in recent years (2014 to early 2025). | Mol Divers | 2026 | 40515964 | PubTator, text mining | PubMed |
| Identify natural compounds as novel phosphodiesterase-2A inhibitors. | J Biomol Struct Dyn | 2026 | 40215195 | PubTator, text mining | PubMed |
| Computational and in vitro binding studies of the redesigned pentoxifylline analogue against phosphodiesterases function in sperm. | J Biomol Struct Dyn | 2026 | 39627993 | PubTator, text mining | PubMed |
| Pharmacological characterization and preclinical evaluation of 11h: a novel, brain-penetrant PDE4 inhibitor for neurological disorders. | Front Pharmacol | 2025 | 41585874 | PubTator, text mining | PubMed |
| Oncogenic Function of miR-182-5p Versus Tumor-Suppressive Activities of miR-203, miR-150-5p, and miR-139-5p via Target Gene Regulation in Colon Cancer Metastasis. | Iran J Pharm Res | 2025 | 41477124 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of Cyclic Nucleotide Phosphodiesterases (PDEs) Expression, Variation, and Prognostic Significance. | ACS Omega | 2025 | 41476499 | PubTator, text mining | PubMed |
| Combining Experimental Assays and Molecular Modeling to Evaluate Monosubstituted Cinnamic Acid Derivatives as PDE4B Inhibitors. | ACS Omega | 2025 | 41476481 | PubTator, text mining | PubMed |
| Multi-cohort genome-wide association analyses reveal loci underlying circulating liver enzyme levels in African-ancestry populations. | Res Sq | 2025 | 41472678 | PubTator, text mining | PubMed |
| Genetic Heterogeneity Underlying Familial Short Stature. | Diagnostics (Basel) | 2025 | 41464128 | PubTator, text mining | PubMed |
| Impaired cAMP-PKA-CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia. | Nat Metab | 2025 | 41224958 | PubTator, text mining | PubMed |
| Design and development of potent roflumilast analogues targeting PDE-4B: selectivity and pharmacokinetic insights. | Bioorg Chem | 2025 | 41205475 | PubTator, text mining | PubMed |
| A fused deep learning approach to transform drug repositioning. | Commun Chem | 2025 | 41198910 | PubTator, text mining | PubMed |
| Emerging in Diabetic Cardiomyopathy: Molecular Pathways and Targets for Therapeutic Intervention. | Drug Dev Res | 2025 | 41183131 | PubTator, text mining | PubMed |
| The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum Disorder. | Pharmaceuticals (Basel) | 2025 | 41155624 | PubTator, text mining | PubMed |
| PDE4D and PDE3B orchestrate distinct cAMP microdomains in 3T3-L1 adipocytes. | Br J Pharmacol | 2025 | 41082906 | PubTator, text mining | PubMed |
| Multidimensional mechanistic analysis elucidates spermatogenesis disruption induced by bisphenol S. | Reprod Toxicol | 2025 | 41072826 | PubTator, text mining | PubMed |
| Metabolomic profiling, in-vitro and in-silico analysis of Ayurvedic formulation Madhumehantak Churna, identifies Ptelatoside A as a potent anti-diabetic biomolecule. | In Silico Pharmacol | 2025 | 41048575 | PubTator, text mining | PubMed |
| TMTCrunch: A Proteomic Atlas of Alternative Splicing for Predicting Splicing-Induced Implications in Aging and Alzheimer's Disease. | J Proteome Res | 2025 | 41024644 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5144/papers?page=3